These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 27071345)

  • 1. Metabolic syndrome and metabolic risk profile according to polycystic ovary syndrome phenotype.
    Bil E; Dilbaz B; Cirik DA; Ozelci R; Ozkaya E; Dilbaz S
    J Obstet Gynaecol Res; 2016 Jul; 42(7):837-43. PubMed ID: 27071345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A case-control observational study of insulin resistance and metabolic syndrome among the four phenotypes of polycystic ovary syndrome based on Rotterdam criteria.
    Jamil AS; Alalaf SK; Al-Tawil NG; Al-Shawaf T
    Reprod Health; 2015 Jan; 12():7. PubMed ID: 25595199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome.
    Moghetti P; Tosi F; Bonin C; Di Sarra D; Fiers T; Kaufman JM; Giagulli VA; Signori C; Zambotti F; Dall'Alda M; Spiazzi G; Zanolin ME; Bonora E
    J Clin Endocrinol Metab; 2013 Apr; 98(4):E628-37. PubMed ID: 23476073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Prevalence of Polycystic Ovary Syndrome, Its Phenotypes and Cardio-Metabolic Features in a Community Sample of Iranian Population: Tehran Lipid and Glucose Study.
    Farhadi-Azar M; Behboudi-Gandevani S; Rahmati M; Mahboobifard F; Khalili Pouya E; Ramezani Tehrani F; Azizi F
    Front Endocrinol (Lausanne); 2022; 13():825528. PubMed ID: 35299965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anthropometric, clinical and laboratory comparison of four phenotypes of polycystic ovary syndrome based on Rotterdam criteria.
    Yilmaz M; Isaoglu U; Delibas IB; Kadanali S
    J Obstet Gynaecol Res; 2011 Aug; 37(8):1020-6. PubMed ID: 21481088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The incidence of metabolic syndrome in adolescents with different phenotypes of PCOS.
    Altintas KZ; Dilbaz B; Cirik DA; Ozelci R; Zengin T; Erginay ON; Dilbaz S
    Ginekol Pol; 2017; 88(6):289-295. PubMed ID: 28727126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Phenotype and metabolic profile of South Asian women with polycystic ovary syndrome (PCOS): results of a large database from a specialist Endocrine Clinic.
    Wijeyaratne CN; Seneviratne Rde A; Dahanayake S; Kumarapeli V; Palipane E; Kuruppu N; Yapa C; Seneviratne Rde A; Balen AH
    Hum Reprod; 2011 Jan; 26(1):202-13. PubMed ID: 21098627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic risk assessment of Indian women with polycystic ovarian syndrome in relation to four Rotterdam criteria based phenotypes.
    Tripathy P; Sahu A; Sahu M; Nagy A
    Eur J Obstet Gynecol Reprod Biol; 2018 May; 224():60-65. PubMed ID: 29550643
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of metabolic syndrome in women with polycystic ovary syndrome.
    Panidis D; Macut D; Tziomalos K; Papadakis E; Mikhailidis K; Kandaraki EA; Tsourdi EA; Tantanasis T; Mavromatidis G; Katsikis I
    Clin Endocrinol (Oxf); 2013 Apr; 78(4):586-92. PubMed ID: 22888988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characteristics of different phenotypes of polycystic ovary syndrome in a Bulgarian population.
    Pehlivanov B; Orbetzova M
    Gynecol Endocrinol; 2007 Oct; 23(10):604-9. PubMed ID: 17852429
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of different phenotypes of polycystic ovary syndrome based on the Rotterdam criteria in a large-scale Chinese population.
    Zhang HY; Zhu FF; Xiong J; Shi XB; Fu SX
    BJOG; 2009 Nov; 116(12):1633-9. PubMed ID: 19781047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of hyperandrogenism and polycystic ovary syndrome in female to male transsexuals.
    Becerra-Fernández A; Pérez-López G; Román MM; Martín-Lazaro JF; Lucio Pérez MJ; Asenjo Araque N; Rodríguez-Molina JM; Berrocal Sertucha MC; Aguilar Vilas MV
    Endocrinol Nutr; 2014; 61(7):351-8. PubMed ID: 24680383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence, phenotype and cardiometabolic risk of polycystic ovary syndrome under different diagnostic criteria.
    Yildiz BO; Bozdag G; Yapici Z; Esinler I; Yarali H
    Hum Reprod; 2012 Oct; 27(10):3067-73. PubMed ID: 22777527
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study.
    Panidis D; Tziomalos K; Misichronis G; Papadakis E; Betsas G; Katsikis I; Macut D
    Hum Reprod; 2012 Feb; 27(2):541-9. PubMed ID: 22144419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characteristics of different phenotypes of polycystic ovary syndrome based on the Rotterdam criteria in the Croatian population.
    Baldani DP; Skrgatić L; Simunić V; Zlopasa G; Canić T; Trgovcić I
    Coll Antropol; 2013 Jun; 37(2):477-82. PubMed ID: 23940993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Atherogenic metabolic profile in PCOS patients: role of obesity and hyperandrogenism.
    Castelo-Branco C; Steinvarcel F; Osorio A; Ros C; Balasch J
    Gynecol Endocrinol; 2010 Oct; 26(10):736-42. PubMed ID: 20569105
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Polycystic ovary syndrome: is there a rise in the prevalence?].
    Carmona-Ruiz IO; Saucedo-de la Llata E; Moraga-Sánchez MR; Romeu-Sarró A
    Ginecol Obstet Mex; 2015 Dec; 83(12):750-9. PubMed ID: 27290799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The frequency of metabolic syndrome is higher among PCOS Brazilian women with menstrual irregularity plus hyperandrogenism.
    Melo AS; Vieira CS; Romano LG; Ferriani RA; Navarro PA
    Reprod Sci; 2011 Dec; 18(12):1230-6. PubMed ID: 22096008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Visceral adiposity index (VAI) is related to the severity of anovulation and other clinical features in women with polycystic ovary syndrome.
    Androulakis II; Kandaraki E; Christakou C; Karachalios A; Marinakis E; Paterakis T; Diamanti-Kandarakis E
    Clin Endocrinol (Oxf); 2014 Sep; 81(3):426-31. PubMed ID: 24601936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid accumulation product as a marker of cardiometabolic susceptibility in women with different phenotypes of polycystic ovary syndrome.
    Božić-Antić I; Ilić D; Bjekić-Macut J; Bogavac T; Vojnović-Milutinović D; Kastratovic-Kotlica B; Milić N; Stanojlović O; Andrić Z; Macut D
    Eur J Endocrinol; 2016 Dec; 175(6):551-560. PubMed ID: 27634940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.